Annual CFI
$180.84 M
NaN%
December 31, 2022
Summary
- As of February 10, 2025, PBAX annual cash flow from investing activities is $180.84 million
Performance
PBAX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$5.69 M
+$5.40 M+1894.67%
September 30, 2023
Summary
- As of February 10, 2025, PBAX quarterly cash flow from investing activities is $5.69 million, with the most recent change of +$5.40 million (+1894.67%) on September 30, 2023.
- Over the past year, PBAX quarterly CFI has increased by +$5.56 million (+4327.08%).
Performance
PBAX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$186.58 M
+$5.56 M+3.07%
September 30, 2023
Summary
- As of February 10, 2025, PBAX TTM cash flow from investing activities is $186.58 million, with the most recent change of +$5.56 million (+3.07%) on September 30, 2023.
- Over the past year, PBAX TTM CFI has increased by +$186.46 million (+145102.26%).
Performance
PBAX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PBAX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +4327.1% | +10000.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PBAX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -96.9% | -101.8% | at high | -100.0% |
| 5 y | 5-year | at high | at low | -96.9% | -101.8% | at high | -100.0% |
| alltime | all time | at high | at low | -96.9% | -101.8% | at high | -100.0% |
Phoenix Biotech Acquisition Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $5.69 M(+1894.7%) | $186.58 M(+3.1%) |
| Jun 2023 | - | $285.20 K(-385.2%) | $181.02 M(+0.2%) |
| Mar 2023 | - | -$100.00 K(-100.1%) | $180.74 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $180.84 M | $180.71 M(>+9900.0%) | $180.84 M(>+9900.0%) |
| Sep 2022 | - | $128.50 K(>+9900.0%) | $128.50 K(>+9900.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00 | $0.00 |
FAQ
- What is Phoenix Biotech Acquisition annual cash flow from investing activities?
- What is the all time high annual CFI for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly CFI year-on-year change?
- What is Phoenix Biotech Acquisition TTM cash flow from investing activities?
- What is the all time high TTM CFI for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition TTM CFI year-on-year change?
What is Phoenix Biotech Acquisition annual cash flow from investing activities?
The current annual CFI of PBAX is $180.84 M
What is the all time high annual CFI for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high annual cash flow from investing activities is $180.84 M
What is Phoenix Biotech Acquisition quarterly cash flow from investing activities?
The current quarterly CFI of PBAX is $5.69 M
What is the all time high quarterly CFI for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high quarterly cash flow from investing activities is $180.71 M
What is Phoenix Biotech Acquisition quarterly CFI year-on-year change?
Over the past year, PBAX quarterly cash flow from investing activities has changed by +$5.56 M (+4327.08%)
What is Phoenix Biotech Acquisition TTM cash flow from investing activities?
The current TTM CFI of PBAX is $186.58 M
What is the all time high TTM CFI for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high TTM cash flow from investing activities is $186.58 M
What is Phoenix Biotech Acquisition TTM CFI year-on-year change?
Over the past year, PBAX TTM cash flow from investing activities has changed by +$186.46 M (+145102.26%)